Stanford researchers have engineered yeast strains for de novo biosynthesis of tetrahydropapaverine (THP) and a semi-synthetic production of papaverine with high efficiency.
Stanford researchers in the Swartz lab have developed a method for improving the productivity of biosynthetic processes via enzymatic detoxification of aberrant forms of NAD(P)H.
Stanford inventors have developed a cell-free method for carbon-negative biosynthetic production of commodity biochemicals by using hydrogen gas as a source of reducing equivalents.
Stanford researchers in the Swartz lab have proposed a method to synthesize metabolic cofactors from inexpensive substrates for protein synthesis and commodity production applications.